Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-24 @ 5:33 PM
NCT ID:
NCT07240168
Eligibility Criteria:
Inclusion Criteria:
* Age \>8 years
* Diagnosis of ulcerative colitis (self-reported)
* Completed Evinature clinical assessment between April 1, 2022, and cutoff date
* Vedolizumab treatment at baseline
* Active disease at entry (SCCAI ≥3 or PRO-2 ≥2 with RB ≥1)
* Initiated CurQD at entry
Exclusion Criteria:
* Vedolizumab for indications other than UC
* Unclear medication status at baseline
* Not active disease when starting CurQD
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Study:
NCT07240168
Study Brief:
Protocol Section:
NCT07240168